Physician profile
Erick Calderon
NPI 1912904855
$10,281.87
in general payments reported to CMS, 2019-2025
47 companies · $1,502 in 2025
The $1,502 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,709 · 2020: $792 · 2021: $1,121 · 2022: $1,898 · 2023: $1,572 · 2024: $1,687 · 2025: $1,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,761.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,096.81 | 2019-2025 | Repatha, Repatha |
| Penumbra, INC. | $1,068.64 | 2019-2025 | Indigo System, Penumbra System |
| Astrazeneca Pharmaceuticals LP | $822.74 | 2019-2025 | Farxiga, Andexxa |
| Boston Scientific Corporation | $748.13 | 2019-2024 | Varithena Administration Pack, Watchman Access System |
| Inari Medical, INC. | $682.27 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cvrx, INC. | $643.93 | 2022-2025 | Barostim Neo System |
| Philips North America LLC | $618.95 | 2020-2025 | (Br5) Peripheral Ivus, (Ck7) Extended Holter, (9282) Turbo Power |
| Janssen Pharmaceuticals, INC | $479.53 | 2019-2024 | Xarelto |
| Stryker Corporation | $444.61 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $418.80 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $386.68 | 2019-2025 | |
| Abbott Laboratories | $264.66 | 2019-2024 | Mitraclip, Confirm Rx |
| Sanofi-Aventis U.S. LLC | $261.19 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $241.74 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $233.69 | 2021-2024 | Verquvo |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $194.30 | 2020-2025 | Biomonitor, Amvia Edge |
| Astellas Pharma US INC | $181.74 | 2019-2022 | |
| Pfizer INC. | $138.71 | 2022-2025 | |
| Amarin Pharma, INC. | $118.30 | 2019 | |
| Cardinal Health 200 LLC | $109.92 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $103.60 | 2021-2025 | Eliquis, Camzyos |
| G Medical Diagnostic Services, INC. | $100.62 | 2019-2024 | Cardiac Monitoring Suite |
| Alnylam Pharmaceuticals INC. | $96.49 | 2019-2025 | Onpattro |
| Siemens Medical Solutions USA, INC. | $89.85 | 2021-2022 | |
| Cardiovascular Systems INC. | $87.63 | 2019-2021 | |
| Novo Nordisk INC | $85.38 | 2025 | Wegovy |
| Corvista Health, INC. | $67.36 | 2025 | Corvista System |
| Medtronic Vascular, INC. | $60.08 | 2019-2020 | |
| Abiomed | $46.93 | 2022-2023 | Impella |
| Lexicon Pharmaceuticals, INC. | $42.94 | 2023-2024 | Inpefa |
| Ekos Corporation | $41.77 | 2019 | |
| Medtronic, INC. | $36.64 | 2021 | |
| Glaxosmithkline, LLC. | $29.83 | 2025 | Arexvy, Shingrix |
| United Therapeutics Corporation | $22.50 | 2021 | |
| Azurity Pharmaceuticals, INC. | $21.93 | 2023 | Edarbi |
| Cashflow Solutions, LLC | $20.53 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Sun Pharmaceutical Industries INC. | $18.64 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $18.42 | 2024 | Arcalyst |
| Silk Road Medical, INC. | $17.95 | 2021 | |
| Daiichi Sankyo INC. | $17.75 | 2024 | Injectafer |
| Scpharmaceuticals INC. | $17.08 | 2024 | |
| Kestra Medical Technology Services, INC. | $16.70 | 2022 | |
| Medicomp INC | $14.89 | 2021 | |
| Sobi, INC | $14.55 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $13.42 | 2023 | Arcalyst |
| Jubilant Draximage, INC. | $13.05 | 2025 | Technetium Tc 99m Sestamibi |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erick Calderon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.